The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 3, Pages 937
Publisher
MDPI AG
Online
2020-01-31
DOI
10.3390/ijms21030937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Platinum Resistance in Ovarian Cancer: Role of DNA Repair
- (2019) Giovanna Damia et al. Cancers
- Crucial role of the pentose phosphate pathway in malignant tumors (Review)
- (2019) Lin Jin et al. Oncology Letters
- 1-Hydroxy-8-methoxy-anthraquinon reverses cisplatin resistance by inhibiting 6PGD in cancer cells
- (2019) Huamin Zhang et al. Open Life Sciences
- The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy
- (2018) Eunae Sandra Cho et al. Biomolecules & Therapeutics
- ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells
- (2018) Yunjie Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Glutathione metabolism in cancer progression and treatment resistance
- (2018) Ankita Bansal et al. JOURNAL OF CELL BIOLOGY
- A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
- (2018) Luigi Mele et al. Cell Death & Disease
- Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells
- (2018) Daniela Catanzaro et al. Oncotarget
- Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System
- (2018) Weipeng Hong et al. Frontiers in Pharmacology
- Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
- (2018) Sergio Giannattasio et al. Frontiers in Oncology
- Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
- (2017) Wujian Zheng et al. Frontiers in Pharmacology
- miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells
- (2016) Li-Ping Zeng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1–AMPK signalling
- (2015) Ruiting Lin et al. NATURE CELL BIOLOGY
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
- (2015) Giuseppe Lucarelli et al. Oncotarget
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin
- (2014) Nasma D. Eljack et al. Metallomics
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- Increased expression of miR-222 is associated with poor prognosis in bladder cancer
- (2014) Dong-qing Zhang et al. World Journal of Surgical Oncology
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Regulation of the pentose phosphate pathway in cancer
- (2014) Peng Jiang et al. Protein & Cell
- Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
- (2013) E. B. Butler et al. CANCER RESEARCH
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy
- (2012) Santiago Gómez-Ruiz et al. BIOINORGANIC CHEMISTRY AND APPLICATIONS
- The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
- (2012) Chiara Riganti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- (2011) M. Garofalo et al. CURRENT MOLECULAR MEDICINE
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Mechanisms of Cisplatin Nephrotoxicity
- (2010) Ronald P. Miller et al. Toxins
- Polymer−Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action
- (2009) Gianfranco Pasut et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search